SAM
HAE icon

Shell Asset Management’s Haemonetics HAE Stock Holding History

Shell Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$42K Sell
868
-1,278
-60% -$79.1K ﹤0.01% 911
2025
Q2 		$160K Sell
2,146
-533
-20% -$35.3K 0.01% 846
2025
Q1 		$170K Sell
2,679
-116
-4% -$7.89K 0.01% 850
2024
Q4 		$218K Hold
2,795
– – 0.01% 805
2024
Q3 		$225K Buy
+2,795
New +$226K 0.01% 782
2024
Q1 		$245K Sell
2,956
-298
-9% -$23.4K 0.01% 749
2023
Q4 		$278K Sell
3,254
-979
-23% -$84.6K 0.01% 738
2023
Q3 		$379K Sell
4,233
-67
-2% -$5.98K 0.02% 674
2023
Q2 		$366K Sell
4,300
-25
-0.6% -$2.11K 0.01% 712
2023
Q1 		$358K Sell
4,325
-15
-0.3% -$1.21K 0.01% 709
2022
Q4 		$341K Sell
4,340
-952
-18% -$76.5K 0.01% 717
2022
Q3 		$392K Sell
5,292
-1,376
-21% -$98.8K 0.02% 692
2022
Q2 		$435K Buy
6,668
+18
+0.3% +$1.06K 0.01% 788
2022
Q1 		$420K Sell
6,650
-978
-13% -$53.2K 0.01% 892
2021
Q4 		$405K Buy
7,628
+20
+0.3% +$1.22K 0.01% 988
2021
Q3 		$537K Sell
7,608
-330
-4% -$20.8K 0.01% 841
2021
Q2 		$529K Buy
7,938
+430
+6% +$30.4K 0.01% 885
2021
Q1 		$833K Sell
7,508
-50
-0.7% -$6.19K 0.02% 612
2020
Q4 		$898K Hold
7,558
– – 0.02% 541
2020
Q3 		$659K Hold
7,558
– – 0.02% 571
2020
Q2 		$677K Sell
7,558
-67
-0.9% -$6.77K 0.02% 544
2020
Q1 		$760K Sell
7,625
-116
-1% -$12.6K 0.02% 504
2019
Q4 		$889K Sell
7,741
-155
-2% -$18.8K 0.02% 594
2019
Q3 		$996K Sell
7,896
-68
-0.9% -$8.63K 0.02% 531
2019
Q2 		$958K Sell
7,964
-182
-2% -$17.9K 0.02% 576
2019
Q1 		$713K Hold
8,146
– – 0.02% 738
2018
Q4 		$815K Sell
8,146
-700
-8% -$73.5K 0.02% 608
2018
Q3 		$1.01M Buy
+8,846
New +$916K 0.02% 654

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shell Asset Management's HAE Position: Q3 2025 in Review

Shell Asset Management reduced its Haemonetics (HAE) stake by 60% in Q3 2025, selling an estimated $79.1K and leaving 868 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #911.

Shell Asset Management first reported a position in HAE in Q3 2018 and has held it in 28 quarters since. The position peaked at $1.01M in Q3 2018. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Shell Asset Management held 868 shares of Haemonetics worth $42K as of Q3 2025.
  • Shell Asset Management sold 1,278 Haemonetics shares in Q3 2025, an estimated $79.1K.
  • Haemonetics made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #911 holding.
  • Shell Asset Management first reported a position in Haemonetics in Q3 2018 and has held it in 28 quarters since.
  • Shell Asset Management's Haemonetics position peaked at $1.01M in Q3 2018.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.